Find similar content

Source channel @githubtrending · Post #14815 · Jun 10

#jupyter_notebook#chatglm#chatglm3#gemma_2b_it#glm_4#internlm2#llama3#llm#lora#minicpm#q_wen#qwen#qwen1_5#qwen2 This guide helps beginners set up and use open-source large language models (LLMs) on Linux or cloud platforms like AutoDL, with step-by-step instructions for environment setup, model deployment, and fine-tuning for models such as LLaMA, ChatGLM, and InternLM[2][4][5]. It covers everything from basic installation to advanced techniques like LoRA and distributed fine-tuning, and supports integration with tools like LangChain and online demo deployment. The main benefit is making powerful AI models accessible and easy to use for students, researchers, and anyone interested in experimenting with or customizing LLMs for their own projects[2][4][5]. https://github.com/datawhalechina/self-llm

Hashtags

#jupyter_notebook #chatglm #chatglm3 #gemma_2b_it #glm_4 #internlm2 #llama3 #llm #lora #minicpm #q_wen #qwen #qwen1_5 #qwen2

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment